THE MILLION WOMEN STUDY

Rejuvime Medical • October 7, 2015

The Million Women Study was conducted by The University of Oxford with the goal of recruiting women in the UK to answer the following questions:

What effects do combined oestrogen and progestagen hormone replacement therapy (HRT) preparations have on breast cancer risk?

Are breast cancers detected at screening in women who have used HRT or oral contraceptives different in terms of size and invasiveness from the cancers detected in women who have never used these hormones?

How does HRT use affect the efficacy of breast cancer screening?

How does HRT use affect mortality from breast cancer and other conditions?

Visit the link below to view the current progress of this study:

 

Get in Touch

Questions? Contact us today by phone or book an appointment online.

Questions? Call our office:

(225) 228-3128

maintain weight loss after oral glp-1 therapy
By Rejuvime Medical March 29, 2026
Learn how to maintain weight loss after GLP-1 with hormone optimization, muscle preservation, and a medically guided long-term plan.
Metabolic testing and glp-1 therapy
By Rejuvime Medical March 27, 2026
See why metabolic testing before GLP-1 improves results. Learn how labs, hormones, and personalized protocols drive more effective weight loss.
Local in person glp-1 treatment
By Rejuvime Medical March 26, 2026
Compare telehealth vs in-person GLP-1 care. Discover why local clinics with testing, monitoring, and physician oversight deliver better results.
Show More